Mineki Saito Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

4/2004

Serum concentration and genetic polymorphism in the 5'-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individuals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mineki Saito Research Topics

Disease

19	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 01/2020 - 04/2003
10	Infections 01/2020 - 10/2004
7	Spinal Cord Diseases 12/2017 - 07/2003
7	T-Cell Leukemia (Leukemia, T Cell) 12/2017 - 02/2009
5	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2019 - 02/2009
2	Multiple Sclerosis 12/2017 - 04/2008
2	Virus Diseases (Viral Diseases) 10/2010 - 07/2003
2	Disease Susceptibility (Diathesis) 12/2007 - 03/2005
1	RNA Virus Infections 01/2021
1	Lymphoma (Lymphomas) 10/2017
1	Human Influenza (Influenza) 01/2017
1	Testicular Neoplasms (Testicular Cancer) 01/2017
1	Allergic Contact Dermatitis 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 05/2013
1	Inflammation (Inflammations) 05/2013
1	Neoplasms (Cancer) 01/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2008
1	Inclusion Body Myositis 01/2008
1	Vasculitis (Vasculitides) 02/2006
1	Collagen Diseases (Collagen Disease) 02/2006
1	Communicable Diseases (Infectious Diseases) 05/2005
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2004
1	HTLV-I Infections (HTLV-I Infection) 04/2003
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2002
1	Disease Progression 12/2002
1	Miyoshi myopathy 12/2002

Drug/Important Bio-Agent (IBA)

4	Monoclonal AntibodiesIBA 06/2014 - 10/2010
3	Messenger RNA (mRNA)IBA 12/2019 - 02/2009
3	LigandsIBA 12/2017 - 07/2003
2	CytokinesIBA 12/2019 - 04/2003
2	Trans-Activators (Trans-Acting Factor)IBA 12/2017 - 05/2013
2	VaccinesIBA 01/2017 - 06/2014
2	AntibodiesIBA 06/2014 - 04/2008
2	HLA-DRB1 Chains (HLA DRB1)IBA 12/2007 - 03/2005
2	Interferon-alpha (Interferon Alfa)IBA 07/2006 - 01/2004
1	Attenuated VaccinesIBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2020
1	Viral RNAIBA 11/2019
1	CC ChemokinesIBA 12/2017
1	Minocycline (Cyclops)FDA LinkGeneric 12/2017
1	Chemotactic FactorsIBA 12/2017
1	CalciumIBA 10/2017
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2017
1	Therapeutic UsesIBA 01/2017
1	AutoantibodiesIBA 01/2017
1	AntigensIBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 04/2016
1	Immunoglobulin G (IgG)IBA 06/2014
1	Pharmaceutical PreparationsIBA 06/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	EpitopesIBA 10/2011
1	Biological ProductsIBA 10/2010
1	OX40 LigandIBA 10/2010
1	ChemokinesIBA 10/2010
1	Oncogene Proteins (Oncogene Protein)IBA 08/2010
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 04/2008
1	CX3C Chemokine Receptor 1IBA 03/2008
1	HTLV-I AntibodiesIBA 01/2008
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 12/2007
1	Peptides (Polypeptides)IBA 12/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2006
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2006
1	Aggrecans (Aggrecan)IBA 01/2006
1	Vitamin D FDA LinkGeneric 05/2005
1	Calcitriol Receptors (Calcitriol Receptor)IBA 05/2005
1	methyl 4-azidophenylacetimidate (APAI)IBA 05/2005
1	HLA-A Antigens (HLA-A)IBA 03/2005
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2004
1	InterleukinsIBA 10/2004
1	Interleukin-10 (Interleukin 10)IBA 10/2004
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2004
1	InterferonsIBA 01/2004
1	Antiviral Agents (Antivirals)IBA 07/2003
1	DysferlinIBA 12/2002

Therapy/Procedure

2	Therapeutics 07/2006 - 01/2004
1	Immunotherapy 01/2013
1	Ligation 10/2011
1	Oral Administration 10/2005